GCAT Stock Overview
Caracal Gold plc engages in the exploration, development, and mining of gold properties in East Africa. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Caracal Gold Plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.0027 |
52 Week High | UK£0.0055 |
52 Week Low | UK£0.0018 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -21.43% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -71.05% |
Recent News & Updates
Recent updates
Shareholder Returns
GCAT | GB Metals and Mining | GB Market | |
---|---|---|---|
7D | 0% | -3.4% | -0.1% |
1Y | -21.4% | -8.3% | 5.5% |
Return vs Industry: GCAT exceeded the UK Metals and Mining industry which returned -26.1% over the past year.
Return vs Market: GCAT underperformed the UK Market which returned -5.2% over the past year.
Price Volatility
GCAT volatility | |
---|---|
GCAT Average Weekly Movement | n/a |
Metals and Mining Industry Average Movement | 7.4% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.2% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: GCAT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GCAT's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 496 | Robbie McCrae | caracalgold.com |
Caracal Gold plc engages in the exploration, development, and mining of gold properties in East Africa. It primarily holds a 100% interest in the Kilimapesa gold mine located in Narok County, Kenya; and the Nyakafuru Gold project comprising 11 granted exploration licenses that covers an area of approximately 280 square kilometers situated in Lake Victoria Gold Fields, Tanzania. Caracal Gold plc is based in London, the United Kingdom.
Caracal Gold Plc Fundamentals Summary
GCAT fundamental statistics | |
---|---|
Market cap | UK£6.11m |
Earnings (TTM) | -UK£10.37m |
Revenue (TTM) | UK£4.57m |
0.0x
P/S Ratio0.0x
P/E RatioIs GCAT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GCAT income statement (TTM) | |
---|---|
Revenue | UK£4.57m |
Cost of Revenue | UK£6.00m |
Gross Profit | -UK£1.43m |
Other Expenses | UK£8.93m |
Earnings | -UK£10.37m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did GCAT perform over the long term?
See historical performance and comparison